Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-06-08 @ 5:59 PM
Study NCT ID:
NCT00915018
Status:
COMPLETED
Last Update Posted:
2018-08-22
First Post:
2009-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3144A2-3005 / B1891005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None